2-[(4-氯苯基)磺酰]硫代乙酰胺 | 59865-87-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-[(4-氯苯基)磺酰]硫代乙酰胺
• 中文别名: 2-(4-氯苯基)磺酰硫代乙酰胺
• 英文名称: 2-(4-chloro-benzenesulfonyl)-thioacetamide
• 英文别名: (4-Chlor-benzolsulfonyl)-thioessigsaeure-amid；(4-Chlor-phenylsulfon)-thioessigsaeure-amid；2-[(4-Chlorophenyl)sulfonyl]ethanethioamide；2-(4-chlorophenyl)sulfonylethanethioamide
• CAS: 59865-87-1
• 化学式: C₈H₈ClNO₂S₂
• mdl: MFCD00052824
• 分子量: 249.742
• InChiKey: OGQJCNYNVJXWBB-UHFFFAOYSA-N

物化性质

• 熔点：
  188 °C
• 稳定性/保质期：
  避免接触氧化物

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.125
• 拓扑面积：
  101
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S37/39
• 危险类别码：
  R36/37/38
• 海关编码：
  2930909090

SDS

Name:	2-[(4-Chlorophenyl)sulfonyl]ethanethioamide 97% Material Safety Data Sheet
Synonym:
CAS:	59865-87-1

Section 1 - Chemical Product MSDS Name:2-[(4-Chlorophenyl)sulfonyl]ethanethioamide 97% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
59865-87-1	2-[(4-Chlorophenyl)sulfonyl]ethanethio	97%	unlisted

Hazard Symbols: XI
Risk Phrases: 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 59865-87-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 188 - 192 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C8H8ClNO2S2
Molecular Weight: 250

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Oxidizing agents, bases.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 59865-87-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-[(4-Chlorophenyl)sulfonyl]ethanethioamide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 59865-87-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 59865-87-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 59865-87-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-(2-bromo-acetyl)-2-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid ethyl ester 、 2-[(4-氯苯基)磺酰]硫代乙酰胺 以 乙醇 为溶剂， 反应 0.12h， 生成 ethyl 5-[2-({[(4-chlorophenyl)methyl]sulfonyl}methyl)(1,3-thiazol-4-yl)]-2-methyl-6-oxo-1,6-dihydro-3-pyridinecarboxylate
  参考文献：
  名称：

  Pyrid-2-one derivatives and methods of use

  摘要：

  所选化合物对于治疗疾病，如细胞增殖或凋亡介导的疾病，具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药学上可接受的衍生物，以及用于预防和治疗涉及中风、癌症等疾病和其他疾病或病况的药物组合物和方法。该主题发明还涉及制备此类化合物的方法，以及在这些过程中有用的中间体。

  公开号：

  US20040147561A1
• 作为产物：
  描述：

  (4-氯苯磺酰)乙腈 在 硫化氢 、 氨 作用下， 生成 2-[(4-氯苯基)磺酰]硫代乙酰胺
  参考文献：
  名称：

  Troeger; Hille, Journal fur praktische Chemie (Leipzig 1954), 1905, vol. <2> 71, p. 232

  摘要：

  DOI：

文献信息

• 3-Bromocyclohexane-1,2-dione as a useful reagent for Hantzsch synthesis of thiazoles and the synthesis of related heterocycles
  作者：Jason M. Guernon、Yong-Jin Wu

  DOI：10.1016/j.tetlet.2011.05.028

  日期：2011.7

  We describe the use of 3-bromocyclohexane-1,2-dione, an air stable, versatile reagent for the Hantzsch thiazole synthesis and the synthesis of other closely related heterocycles.

  我们描述了使用3-溴环己烷-1，2-二酮（一种空气稳定的通用试剂）用于汉茨噻唑的合成以及其他紧密相关的杂环的合成。
• Design and synthesis of quinolin-2(1H)-one derivatives as potent CDK5 inhibitors
  作者：Wenge Zhong、Hu Liu、Matthew R. Kaller、Charles Henley、Ella Magal、Thomas Nguyen、Timothy D. Osslund、David Powers、Robert M. Rzasa、Hui-Ling Wang、Weiya Wang、Xiaoling Xiong、Jiandong Zhang、Mark H. Norman

  DOI：10.1016/j.bmcl.2007.07.045

  日期：2007.10

  Using active site homology modeling between CDK5 and CDK2, we explored several different chemical series of potent CDK5 inhibitors. In this report, we describe the design, synthesis, and CDK5 inhibitory activities of quinolin-2(1H)-one derivatives.

  细胞周期蛋白依赖性激酶5（CDK5）是一种丝氨酸/苏氨酸蛋白激酶，其失调与许多神经退行性疾病（例如阿尔茨海默氏病，肌萎缩性侧索硬化症和缺血性中风）有关。使用CDK5和CDK2之间的活性位点同源性建模，我们探索了有效的CDK5抑制剂的几种不同化学系列。在此报告中，我们描述了喹啉2（1H）-one衍生物的设计，合成和CDK5抑制活性。
• Compounds and methods of use
  申请人：Norman H. Mark

  公开号：US20070032518A1

  公开（公告）日：2007-02-08

  Selected compounds are effective for treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable derivatives thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stroke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  所选化合物对于治疗细胞增殖或凋亡介导的疾病具有有效性。该发明涵盖了新颖的化合物、类似物、前药和其药学上可接受的衍生物、药物组成物以及用于预防和治疗中风、癌症等疾病和其他疾病或病况的方法。该发明还涉及制备这样的化合物的过程，以及在这样的过程中有用的中间体。
• Novel selective thiazoleacetic acids as CRTH2 antagonists developed from in silico derived hits. Part 2
  作者：Marie Grimstrup、Øystein Rist、Jean-Marie Receveur、Thomas M. Frimurer、Trond Ulven、Jesper M. Mathiesen、Evi Kostenis、Thomas Högberg

  DOI：10.1016/j.bmcl.2009.12.015

  日期：2010.2

  Structure-activity relationships have been established by exploring the eastern and western side of 5-thiazolyleacetic acids as CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) antagonists. Benzhydryl motifs in the 2-position of the thiazole was found to be most advantageous. The 4-thiazole position should either carry 3- or 4-fluorophenyl rings or a 4-pyridyl suitably substituted in the flanking 2-position. Several compounds with single digit nanomolar binding affinity and full antagonistic efficacy for human CRTH2 receptor were obtained. The compound series display a good PK profile and selectivity over a large number of other targets. (C) 2009 Elsevier Ltd. All rights reserved.
• Abdel-Lateef,M.F.-A. et al., Roczniki Chemii, 1976, vol. 50, p. 323 - 327
  作者：Abdel-Lateef,M.F.-A. et al.

  DOI：——

  日期：——